Recombinant Human BAP1 Protein，His

BAP1, or BRCA1-associated protein-1, is a key tumor suppressor encoded by the BAP1 gene, which plays a pivotal role in cellular processes such as chromatin remodeling, DNA repair, and cell cycle regulation. Dysregulation or loss of BAP1 function is associated with various malignancies, including malignant mesothelioma, uveal melanoma, and several other cancers, highlighting its significance in tumorigenesis. The protein contains a ubiquitin carboxy-terminal (UBR) domain, a nuclear localization sequence, and several other structural motifs, which facilitate its interaction with multiple protein partners involved in the regulation of gene expression and DNA damage response. Research on recombinant BAP1 has gained momentum as scientists seek to understand its biochemical pathways and interactions that govern tumor suppression. This includes the characterization of its enzymatic activity, particularly its role as a deubiquitinase, which is crucial for modulating the stability and activity of various oncogenic proteins. Furthermore, recombinant BAP1 studies have been instrumental in elucidating its impact on cellular signaling pathways, particularly those involving the Hippo pathway, which is implicated in regulating cell proliferation and survival. Given its critical functions, BAP1 is not only a biomarker for cancer predisposition but also a potential therapeutic target, spurring research efforts to develop BAP1-based strategies for cancer treatment. Understanding the molecular mechanisms mediated by BAP1 and how its dysfunction contributes to tumorigenesis can pave the way for novel diagnostic and therapeutic approaches, ultimately aiming to enhance cancer management and patient outcomes.